成大生物：关于冻干人用狂犬病疫苗（人二倍体细胞）获得药品注册证书的公告

Group 1 - The core point of the article is that Chengda Biological has received a drug registration certificate for its lyophilized human rabies vaccine from the National Medical Products Administration [2] Group 2 - Chengda Biological's wholly-owned subsidiary, Chengda Biological (Benxi) Co., Ltd., is the entity that received the registration certificate [2] - The approval of the rabies vaccine indicates a significant milestone for the company in expanding its product offerings in the biopharmaceutical sector [2] - This development may enhance the company's market position and potential revenue streams in the vaccine market [2]